References
- Hormaeche CE. The “in vivo” division and death rates of Salmonella typhimurium in the spleens of naturally resis-tant and susceptible mice measured by the superinfecting phage technique of Meynell. Immunology 1980; 41: 973–979.
- Harrington KA, Hormaeche CE. Expression of the innate resistance gene Ity in mouse Kupffer cells infected with Salmonella typhimurium “in vitro”. Microb Pathogen 1986; 1: 299–306.
- Hormaeche CE, Maskell DJ, Harrington K, Joysey H, Brock J. Mechanisms of natural resistance to mouse typhoid. Bull Eur Physiopathol Respir 1983; 19: 137–142.
- Plant J, Glynn AA. Locating salmonella resistance gene on mouse chromosome 1. Clin Exp Immunol 1979; 37: 1–6.
- Plant J, Glynn AA. Natural resistance to salmonella infection. Delayed hypersensitivity and Ir genes in different strains of mice. Nature 1984; 248: 345–347.
- Hormaeche CE. Genetics of natural resistance to sal-monellae in mice. Immunology 1979; 37: 319–327.
- Hormaeche CE. The natural resistance of radiation chimeras to S. typhimurium C5. Immunology 1979; 37: 329–332.
- Lissner CR, Swanson RN, O’Brien AD. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macro-phages isolated “in vitro”. J Immunol 1983; 131: 3006–3013.
- Maskell DJ, Hormaeche CE. Relapse following cessation of antibiotic therapy for mouse typhoid in resistant and susceptible mice infected with salmonellae of different virulence. J Infect Dis 1985; 152: 1044–1049.
- Bonina L, Carbone M, Matera G, Teti G, Joysey SH, Hormaeche CE, Mastroeni P. Beta-lactam antibiotics (aztreonam, ampicillin, cefazolin, and ceftazidime) in the control and eradication of Salmonella typhimurium in naturally resistant and susceptible mice. J Antimicrob Chemother 1990; 25: 813–823.
- Mastroeni P, Bonina L, Leonardi MS, Carbone M, Berlinghieri MC. Study of aztreonam intracellular kinetics and its relationships with different cell types. In Proceedings of the IV Mediterranean Congress of Chemotherapy, Rhodos, Greece, Chemioterapia 1984; 345–347.
- Easmon CSF, Crane JP. Uptake of ciprofloxacin by human neutrophils. J Antimicrob Chemother 1985; 16: 67–73.
- Easmon CSF, Crane JP, Blowers A. Effect of ciproflox acin on intracellular organisms: “in vitro” and “in vivo” studies. J Antimicrob Chemother 1986; 18, Suppl. D.: 43–48.
- Carlier MB, Scorneaux B, Zenebergh A, Desnottes JF, Tulkens PM. Cellular uptake, localization and activity of fluoroquinolones in uninfected macrophages. J Antimicrob Chemother 1990; 26, Suppl. B: 27–39.
- Easmon CSF. Protective effects of ciprofloxacin in a murine model of salmonella infection. Am J Med 1987; 82, Suppl. 4A: 71–72.
- Fu KP, Hilliard J, Isaacson D, Tobia AJ, Rosenthal ME, McGuire JL. “In vivo” evaluation of ofloxacin in Sal-monella typhimurium infection in mice. J Antimicrob Chemother 1990; 25: 263–268.
- Butler T, Cartagenova M, Dunn D. Treatment of experimental Salmonella typhimurium infection in mice with lomefloxacin. J Antimicrob Chemother 1990; 25: 629–634.
- Cecchetti V, Fravolini A, Fringuelli R, et al. Quinolone-carboxilic acids.2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido(l,2,3-de) (l,4)benzothiazine-6-carboxilic acids. J Med Chem 1987; 30: 465–473.
- Imbimbo BP, Broccali GP, Cesana M, Crema F, Parrinello Attardo G. Inter- and intrasubject variabilities in the pharmacokinetics of rufloxacin after single oral administration to healthy volunteers. Antimicrob Agents Chemother 1991; 35: 390–393.
- Washington JA, Sutter VL. Dilution susceptibility test: agar and macro-broth dilution procedures. In Manual of Clinical Microbiology, 3rd edn (Lennette EH, Balows A, Hausler WJ, Truant JP Eds), ASM, Washington, DC, 1980: 453–458.
- Butler T, Jacobs MR, Farhi D. Treatment of experimental Salmonella typhimurium infection in mice with fleroxacin. Antimicrob Agents Chemother 1988; 32: 791–792.
- Carbon C, Weber P, Levy M, Boussougant Y, Cerf M. Shortterm ciprofloxacin therapy for typhoid fever. J Infect Dis 1987; 155: 833.
- Wang F, Gu XJ, Zhang MF, Tai TY. Treatment of typhoid fever with ofloxacin. J Antimicrob Chemother 1989; 23: 785–788.
- Velmonte MA, Montalban CS. Norfloxacin in the treatment of infections caused by Salmonella typhi. Scand J Infect Dis 1988; 556 (Suppl.): 46–48.